# Teradyne, Inc: overview

TER · Nasdaq · CIK 97210 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ter.md) · [Financials](/companies/ter/financials.md) · [Filings](/companies/ter/filings.md) · [Insiders](/companies/ter/insiders.md)

Latest reported revenue: [$1.33bn](/filings/0001193125-26-327715.md) for Q2 FY2026, three months to 2026-06-28, from the 10-Q filed Jul 31, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-327715).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [737](/filings/0001193125-25-258477.md) | [753 d](/filings/0001193125-26-059002.md) | [686](/filings/0001193125-26-201058.md) | [652](/filings/0001193125-26-327715.md) | [769](/filings/0001193125-25-258477.md) | [1,083 d](/filings/0001193125-26-059002.md) | [1,282](/filings/0001193125-26-201058.md) | [1,329](/filings/0001193125-26-327715.md) |
| Gross margin | % | [59.2%](/filings/0001193125-25-258477.md) | [59.4% d](/filings/0001193125-26-059002.md) | [60.6%](/filings/0001193125-26-201058.md) | [57.2%](/filings/0001193125-26-327715.md) | [58.4%](/filings/0001193125-25-258477.md) | [57.2% d](/filings/0001193125-26-059002.md) | [60.9%](/filings/0001193125-26-201058.md) | [59.8%](/filings/0001193125-26-327715.md) |
| Operating margin | % | [20.6%](/filings/0001193125-25-258477.md) | [20.4% d](/filings/0001193125-26-059002.md) | [17.6%](/filings/0001193125-26-201058.md) | [13.9%](/filings/0001193125-26-327715.md) | [18.9%](/filings/0001193125-25-258477.md) | [27.1% d](/filings/0001193125-26-059002.md) | [36.9%](/filings/0001193125-26-201058.md) | [32.9%](/filings/0001193125-26-327715.md) |
| Net margin | % | [19.8%](/filings/0001193125-25-258477.md) | [19.4% d](/filings/0001193125-26-059002.md) | [14.4%](/filings/0001193125-26-201058.md) | [12.0%](/filings/0001193125-26-327715.md) | [15.5%](/filings/0001193125-25-258477.md) | [23.7% d](/filings/0001193125-26-059002.md) | [31.1%](/filings/0001193125-26-201058.md) | [28.2%](/filings/0001193125-26-327715.md) |
| Diluted EPS | $ per share | [0.89](/filings/0001193125-25-258477.md) | not reported | [0.61](/filings/0001193125-26-201058.md) | [0.49](/filings/0001193125-26-327715.md) | [0.75](/filings/0001193125-25-258477.md) | not reported | [2.53](/filings/0001193125-26-201058.md) | [2.38](/filings/0001193125-26-327715.md) |
| Free cash flow | $m | [114 d](/filings/0001193125-25-258477.md) | [225 d](/filings/0001193125-26-059002.md) | [97.6](/filings/0001193125-26-201058.md) | [132 d](/filings/0001193125-26-327715.md) | [2.4 d](/filings/0001193125-25-258477.md) | [219 d](/filings/0001193125-26-059002.md) | [200](/filings/0001193125-26-201058.md) | [378 d](/filings/0001193125-26-327715.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,703](/filings/0000950170-24-018701.md) | [3,155](/filings/0000950170-25-023784.md) | [2,676](/filings/0001193125-26-059002.md) | [2,820](/filings/0001193125-26-059002.md) | [3,190](/filings/0001193125-26-059002.md) |
| Gross margin | % | [59.6%](/filings/0000950170-24-018701.md) | [59.2%](/filings/0000950170-25-023784.md) | [57.4%](/filings/0001193125-26-059002.md) | [58.5%](/filings/0001193125-26-059002.md) | [58.2%](/filings/0001193125-26-059002.md) |
| Operating margin | % | [32.4%](/filings/0000950170-24-018701.md) | [26.4%](/filings/0000950170-25-023784.md) | [18.7%](/filings/0001193125-26-059002.md) | [21.1%](/filings/0001193125-26-059002.md) | [20.4%](/filings/0001193125-26-059002.md) |
| Net margin | % | [27.4%](/filings/0000950170-24-018701.md) | [22.7%](/filings/0000950170-25-023784.md) | [16.8%](/filings/0001193125-26-059002.md) | [19.2%](/filings/0001193125-26-059002.md) | [17.4%](/filings/0001193125-26-059002.md) |
| Diluted EPS | $ per share | [5.53](/filings/0000950170-24-018701.md) | [4.22](/filings/0000950170-25-023784.md) | [2.73](/filings/0001193125-26-059002.md) | [3.32](/filings/0001193125-26-059002.md) | [3.47](/filings/0001193125-26-059002.md) |
| Free cash flow | $m | [966](/filings/0000950170-24-018701.md) | [415](/filings/0000950170-25-023784.md) | [426](/filings/0001193125-26-059002.md) | [474](/filings/0001193125-26-059002.md) | [450](/filings/0001193125-26-059002.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ter/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-21 | [Matz Marilyn](/insiders/1618274.md) | Director | Sale (S) | 400 | $350.00 | $140.0k | [Form 4](/filings/0000904454-26-000526.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $9.40bn | 19,437,021 |  | Added +3,131,834 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.95bn | 10,225,398 |  | Added +49,207 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $4.18bn | 8,633,782 |  | Added +30,864 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.53bn | 7,290,460 |  | Added +320,034 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $3.23bn | 6,683,098 |  | Added +4,162,514 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $2.58bn | 5,570,053 |  | Added +2,699,413 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.22bn | 4,602,292 |  | Added +233,612 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.99bn | 4,105,776 |  | Added +496,271 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $1.35bn | 2,791,700 | Put | Added +2,468,800 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $1.32bn | 2,719,428 |  | Reduced −124,548 |

## Recent filings

[All 1,387 filings](/companies/ter/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 06:00 ET | [8-K](/filings/0001193125-26-434981.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-434981 |
| 2026-08-10 | 16:08 ET | [8-K](/filings/0001193125-26-342367.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-342367 |
| 2026-07-31 | 13:00 ET | [10-Q](/filings/0001193125-26-327715.md) | Quarterly report, period 2026-06-28 | 0001193125-26-327715 |
| 2026-07-29 | 06:00 ET | [8-K](/filings/0001193125-26-321933.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-321933 |
| 2026-05-11 | 08:55 ET | [8-K](/filings/0001193125-26-215848.md) | 5.07 Shareholder vote results | 0001193125-26-215848 |
| 2026-05-01 | 14:30 ET | [10-Q](/filings/0001193125-26-201058.md) | Quarterly report, period 2026-03-29 | 0001193125-26-201058 |
| 2026-04-29 | 06:00 ET | [8-K](/filings/0001193125-26-188706.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-188706 |
| 2026-03-27 | 07:03 ET | [DEF 14A](/filings/0001193125-26-127504.md) | Proxy statement, period 2026-03-25 | 0001193125-26-127504 |
| 2026-02-19 | 14:01 ET | [10-K](/filings/0001193125-26-059002.md) | Annual report, period 2025-12-31 | 0001193125-26-059002 |
| 2026-02-03 | 06:01 ET | [8-K](/filings/0001193125-26-034348.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-034348 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-059002.md), filed Feb 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-28, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/a77591d1-522d-4885-aaee-066da3675aa2)

## About the filer

- CIK: 97210
- Tickers: TER
- Exchange: Nasdaq
- SIC code: 3825 Instruments For Meas & Testing of  Electricity & Elec Signals
- State of incorporation: MA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:02 ET. No prices; not investment advice.